Loading…
Reported covered position: Director of Health Policy and Reimbursement
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Diagnostic Innovation Testing and Knowledge Advancement Act of 2013
Client: F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · Firm: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
H.R. 4015, the SGR Repeal and Medicare Provider Payment Modernization Act of 2014 H.R.2085-"Diagnostic Innovation Testing and Knowledge Advancement Act of 2013" Draft legislation to reform the Clinical Lab Fee Schedule H.R.523-"Protect Medical Innovation Act of 2013" S.232-"Medical Device Access and Innovation Protection Act"
SGR Repeal and Medicare Provider Payment Modernization Act of 2014
Client: F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · Firm: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES via F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
2014 · second_quarter · Q2
) HPV primary screening application before the FDA (no bill) 2) H.R.523-"Protect Medical Innovation Act of 2013" 3) S.232-"Medical Device Access and Innovation Protection Act"
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES via F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
2014 · first_quarter · Q1
Source: Senate LDA
H.R. 4015, the SGR Repeal and Medicare Provider Payment Modernization Act of 2014 H.R.2085-"Diagnostic Innovation Testing and Knowledge Advancement Act of 2013" Draft legislation to reform the Clinical Lab Fee Schedule H.R.523-"Protect Medical Innovation Act of 2013" S.232-"Medical Device Access and Innovation Protection Act"
Protect Medical Innovation Act of 2013
Client: F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · Firm: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
) HPV primary screening application before the FDA (no bill) 2) H.R.523-"Protect Medical Innovation Act of 2013" 3) S.232-"Medical Device Access and Innovation Protection Act"
Protect Medical Innovation Act of 2013
Client: F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · Firm: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
H.R. 4015, the SGR Repeal and Medicare Provider Payment Modernization Act of 2014 H.R.2085-"Diagnostic Innovation Testing and Knowledge Advancement Act of 2013" Draft legislation to reform the Clinical Lab Fee Schedule H.R.523-"Protect Medical Innovation Act of 2013" S.232-"Medical Device Access and Innovation Protection Act"
Medical Device Access and Innovation Protection Act
Client: F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · Firm: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
) HPV primary screening application before the FDA (no bill) 2) H.R.523-"Protect Medical Innovation Act of 2013" 3) S.232-"Medical Device Access and Innovation Protection Act"
Medical Device Access and Innovation Protection Act
Client: F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · Firm: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
H.R. 4015, the SGR Repeal and Medicare Provider Payment Modernization Act of 2014 H.R.2085-"Diagnostic Innovation Testing and Knowledge Advancement Act of 2013" Draft legislation to reform the Clinical Lab Fee Schedule H.R.523-"Protect Medical Innovation Act of 2013" S.232-"Medical Device Access and Innovation Protection Act"
Diagnostic Innovation Testing and Knowledge Advancement Act of 2013
Client: F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · Firm: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
CMS competitive bidding program modification; Regulation of IVDs and LDTs; Protect Medical Innovation Act of 2013-HR 523; H.R.2085-"Diagnostic Innovation Testing and Knowledge Advancement Act of 2013"; CY 2014 Medicare Physician Fee Schedule Rule Proposal legislation (not yet introduced) to direct OIG study on the impact of DTS competitive bidding program on patient care
Diagnostic Innovation Testing and Knowledge Advancement Act of 2013
Client: F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · Firm: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
H.R.2085-"Diagnostic Innovation Testing and Knowledge Advancement Act of 2013"; CY 2014 Medicare Physician Fee Schedule Rule (CMS/HHS); Draft legislation to reform the Clinical Lab Fee Schedule; H.R.523-"Protect Medical Innovation Act of 2013"; S.232-"Medical Device Access and Innovation Protection Act"; The Diabetes Access to Care Coalition; The CLFS Reform Coalition; and The PFS Pathology Payment Coalition.
Protect Medical Innovation Act of 2013
Client: F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · Firm: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
CMS competitive bidding program modification; Regulation of IVDs and LDTs; Protect Medical Innovation Act of 2013-HR 523; H.R.2085-"Diagnostic Innovation Testing and Knowledge Advancement Act of 2013"; CY 2014 Medicare Physician Fee Schedule Rule Proposal legislation (not yet introduced) to direct OIG study on the impact of DTS competitive bidding program on patient care
Protect Medical Innovation Act of 2013
Client: F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · Firm: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
H.R.2085-"Diagnostic Innovation Testing and Knowledge Advancement Act of 2013"; CY 2014 Medicare Physician Fee Schedule Rule (CMS/HHS); Draft legislation to reform the Clinical Lab Fee Schedule; H.R.523-"Protect Medical Innovation Act of 2013"; S.232-"Medical Device Access and Innovation Protection Act"; The Diabetes Access to Care Coalition; The CLFS Reform Coalition; and The PFS Pathology Payment Coalition.
Medical Device Access and Innovation Protection Act
Client: F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · Firm: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
H.R.2085-"Diagnostic Innovation Testing and Knowledge Advancement Act of 2013"; CY 2014 Medicare Physician Fee Schedule Rule (CMS/HHS); Draft legislation to reform the Clinical Lab Fee Schedule; H.R.523-"Protect Medical Innovation Act of 2013"; S.232-"Medical Device Access and Innovation Protection Act"; The Diabetes Access to Care Coalition; The CLFS Reform Coalition; and The PFS Pathology Payment Coalition.
H.R. 4015, the SGR Repeal and Medicare Provider Payment Modernization Act of 2014 H.R.2085-"Diagnostic Innovation Testing and Knowledge Advancement Act of 2013" Draft legislation to reform the Clinical Lab Fee Schedule H.R.523-"Protect Medical Innovation Act of 2013" S.232-"Medical Device Access and Innovation Protection Act"
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES via F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
2013 · fourth_quarter · Q4
H.R.2085-"Diagnostic Innovation Testing and Knowledge Advancement Act of 2013"; CY 2014 Medicare Physician Fee Schedule Rule (CMS/HHS); Draft legislation to reform the Clinical Lab Fee Schedule; H.R.523-"Protect Medical Innovation Act of 2013"; S.232-"Medical Device Access and Innovation Protection Act"; The Diabetes Access to Care Coalition; The CLFS Reform Coalition; and The PFS Pathology Payment Coalition.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES via F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
2013 · third_quarter · Q3
CMS competitive bidding program modification; Regulation of IVDs and LDTs; Protect Medical Innovation Act of 2013-HR 523; H.R.2085-"Diagnostic Innovation Testing and Knowledge Advancement Act of 2013"; CY 2014 Medicare Physician Fee Schedule Rule Proposal legislation (not yet introduced) to direct OIG study on the impact of DTS competitive bidding program on patient care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE